Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.

Li Z, Yamada S, Inenaga S, Imamura T, Wu Y, Wang KY, Shimajiri S, Nakano R, Izumi H, Kohno K, Sasaguri Y.

Br J Cancer. 2011 Jun 7;104(12):1882-9. doi: 10.1038/bjc.2011.166. Epub 2011 May 17.

2.

Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.

Onitsuka K, Shibao K, Nakayama Y, Minagawa N, Hirata K, Izumi H, Matsuo K, Nagata N, Kitazato K, Kohno K, Itoh H.

Cancer Sci. 2003 Jan;94(1):32-6.

3.

Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.

Yamamoto S, Nakamori S, Tsujie M, Takahashi Y, Nagano H, Dono K, Umeshita K, Sakon M, Tomita Y, Hoshida Y, Aozasa K, Kohno K, Monden M.

Pathobiology. 2004;71(1):12-8.

PMID:
14555840
4.

Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.

Gu C, Oyama T, Osaki T, Li J, Takenoyama M, Izumi H, Sugio K, Kohno K, Yasumoto K.

Br J Cancer. 2004 Jan 26;90(2):436-42.

5.

Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.

Kitada S, Yamada S, Kuma A, Ouchi S, Tasaki T, Nabeshima A, Noguchi H, Wang KY, Shimajiri S, Nakano R, Izumi H, Kohno K, Matsumoto T, Sasaguri Y.

Br J Cancer. 2013 Jul 23;109(2):472-81. doi: 10.1038/bjc.2013.331. Epub 2013 Jun 25.

6.

Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.

Shibao K, Izumi H, Nakayama Y, Ohta R, Nagata N, Nomoto M, Matsuo K, Yamada Y, Kitazato K, Itoh H, Kohno K.

Cancer. 2002 Apr 1;94(7):1939-46.

7.

Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.

Harada Y, Izumi H, Noguchi H, Kuma A, Kawatsu Y, Kimura T, Kitada S, Uramoto H, Wang KY, Sasaguri Y, Hijioka H, Miyawaki A, Oya R, Nakayama T, Kohno K, Yamada S.

Tumour Biol. 2016 Jan;37(1):1357-68. doi: 10.1007/s13277-015-3928-7. Epub 2015 Aug 22. Erratum in: Tumour Biol. 2015 Dec;36(12):10003-4.

8.

Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.

Bennett EP, Hassan H, Mandel U, Hollingsworth MA, Akisawa N, Ikematsu Y, Merkx G, van Kessel AG, Olofsson S, Clausen H.

J Biol Chem. 1999 Sep 3;274(36):25362-70.

9.

The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma.

Ishikawa M, Kitayama J, Nariko H, Kohno K, Nagawa H.

J Surg Oncol. 2004 Apr 1;86(1):28-33.

PMID:
15048677
10.

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers.

Dosaka-Akita H, Kinoshita I, Yamazaki K, Izumi H, Itoh T, Katoh H, Nishimura M, Matsuo K, Yamada Y, Kohno K.

Br J Cancer. 2002 Sep 23;87(7):751-5.

11.

The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization.

Arg├╝eso P, Tisdale A, Mandel U, Letko E, Foster CS, Gipson IK.

Invest Ophthalmol Vis Sci. 2003 Jan;44(1):86-92.

PMID:
12506059
12.

Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.

Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N, Matsuo K, Yamada Y, Kohno K, Irimura T.

Clin Cancer Res. 2004 Mar 15;10(6):2090-9.

14.

Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection.

Li Z, Yamada S, Wu Y, Wang KY, Liu YP, Uramoto H, Kohno K, Sasaguri Y.

Oncotarget. 2016 Aug 23;7(34):54463-54473. doi: 10.18632/oncotarget.9810.

15.

Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.

Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, Honke K, Saibara T, Hollingsworth MA.

Oncogene. 2011 Dec 8;30(49):4843-54. doi: 10.1038/onc.2011.194. Epub 2011 May 30.

16.

Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines.

Sutherlin ME, Nishimori I, Caffrey T, Bennett EP, Hassan H, Mandel U, Mack D, Iwamura T, Clausen H, Hollingsworth MA.

Cancer Res. 1997 Nov 1;57(21):4744-8.

17.
18.

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.

Wu C, Guo X, Wang W, Wang Y, Shan Y, Zhang B, Song W, Ma S, Ge J, Deng H, Zhu M.

BMC Cancer. 2010 Apr 1;10:123. doi: 10.1186/1471-2407-10-123.

19.

Correlation of polypeptide N-acetylgalactosamine transferases-3 and -6 to different stages of endometriosis.

Xu X, Fei X, Ma J, Qu Y, Zhou C, Xu K, Lin J.

Arch Gynecol Obstet. 2017 Jun;295(6):1413-1419. doi: 10.1007/s00404-017-4344-6. Epub 2017 Apr 5.

PMID:
28382414
20.

Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.

Kato K, Takeuchi H, Kanoh A, Miyahara N, Nemoto-Sasaki Y, Morimoto-Tomita M, Matsubara A, Ohashi Y, Waki M, Usami K, Mandel U, Clausen H, Higashi N, Irimura T.

Glycoconj J. 2010 Feb;27(2):267-76. doi: 10.1007/s10719-009-9275-4.

PMID:
20077002

Supplemental Content

Support Center